From ocular oncology to tackling neglected diseases, our 2020 Power Listers are making their mark on ophthalmology – and beyond.
Progress in ophthalmology doesn’t always come from increased complexity
Leading ophthalmic bodies warn that COVID-19 can be transmitted through aerosol contact with the conjunctiva
How surgical adjuncts can make cataract surgery safer – and minimize costs in the long run
When it comes to brain mapping diversity, size – or rather, pattern – matters
Michael D. Abramoff,
Four deep learning experts discuss the ethical implications of using advanced technologies in eye care – and potential solutions
A newly-identified mutation in monkeys could spur development of cell and gene therapies for BBS
Could the ELOVL2 gene be the key to new therapeutics for age-related eye diseases?
How will mitomycin C shortages affect glaucoma surgery?
Diagnosing and treating dry eye is the physician’s responsibility – but success demands involvement from the whole team
A 70-year overview of Allergan's most profitable product
Send me the latest from The Ophthalmologist.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.